<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />

<meta name="author" content="ClinicoPath Development Team" />

<meta name="date" content="2025-06-30" />

<title>Stage Migration Analysis: Understanding the Will Rogers Phenomenon</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>







<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Stage Migration Analysis: Understanding the
Will Rogers Phenomenon</h1>
<h4 class="author">ClinicoPath Development Team</h4>
<h4 class="date">2025-06-30</h4>



<div id="introduction" class="section level1">
<h1>Introduction</h1>
<p>The Will Rogers phenomenon is a statistical paradox that occurs in
medicine when patients are reclassified between disease stages due to
improvements in diagnostic technology or changes in staging criteria.
This phenomenon gets its name from a humorous quote attributed to
American humorist Will Rogers: “When the Okies left Oklahoma and moved
to California, they raised the average intelligence level in both
states.”</p>
<p>In pathology and oncology, this phenomenon is particularly relevant
when analyzing the impact of staging system revisions (such as TNM
edition updates) on survival outcomes and treatment effectiveness.</p>
<div id="what-is-the-will-rogers-phenomenon" class="section level2">
<h2>What is the Will Rogers Phenomenon?</h2>
<p>The Will Rogers phenomenon describes a situation where:</p>
<ol style="list-style-type: decimal">
<li><p><strong>Stage Migration Occurs</strong>: Patients are
reclassified into different disease stages due to improved diagnostic
methods or revised staging criteria.</p></li>
<li><p><strong>Apparent Improvement</strong>: This reclassification
leads to apparent improvements in stage-specific outcomes without any
actual improvement in individual patient outcomes.</p></li>
<li><p><strong>Statistical Paradox</strong>: Both stages appear to have
improved survival rates, but overall survival remains
unchanged.</p></li>
</ol>
<div id="clinical-example" class="section level3">
<h3>Clinical Example</h3>
<p>Consider lung cancer staging between TNM 7th and 8th editions:</p>
<ul>
<li><strong>Original System (7th Edition)</strong>: A patient with a
3.5cm tumor and 2 positive lymph nodes is classified as Stage II</li>
<li><strong>New System (8th Edition)</strong>: The same patient is now
classified as Stage IIB due to refined criteria</li>
</ul>
<p>If this patient has better survival than the average Stage II patient
but worse survival than the average Stage IIB patient:</p>
<ul>
<li>Stage II survival improves (worst patients removed)</li>
<li>Stage IIB survival improves (relatively good patients added)</li>
<li>The patient’s actual prognosis hasn’t changed</li>
</ul>
</div>
</div>
<div id="the-stage-migration-analysis-module" class="section level2">
<h2>The Stage Migration Analysis Module</h2>
<p>The Stage Migration Analysis module in ClinicoPath helps you:</p>
<ol style="list-style-type: decimal">
<li><strong>Quantify stage migration</strong> between different staging
systems</li>
<li><strong>Compare prognostic performance</strong> of old vs. new
staging systems</li>
<li><strong>Visualize migration patterns</strong> using flow
diagrams</li>
<li><strong>Detect the Will Rogers phenomenon</strong> through
statistical analysis</li>
<li><strong>Evaluate staging system improvements</strong>
objectively</li>
</ol>
</div>
</div>
<div id="getting-started" class="section level1">
<h1>Getting Started</h1>
<div id="required-data" class="section level2">
<h2>Required Data</h2>
<p>To perform stage migration analysis, you need:</p>
<ol style="list-style-type: decimal">
<li><strong>Patient identifiers</strong></li>
<li><strong>Original staging variable</strong> (e.g., TNM 7th edition
stages)</li>
<li><strong>New staging variable</strong> (e.g., TNM 8th edition
stages)</li>
<li><strong>Survival time</strong> (in consistent units: months,
years)</li>
<li><strong>Event indicator</strong> (death, progression, etc.)</li>
</ol>
</div>
<div id="data-format" class="section level2">
<h2>Data Format</h2>
<p>Your data should look like this:</p>
<table style="width:100%;">
<colgroup>
<col width="16%" />
<col width="15%" />
<col width="15%" />
<col width="23%" />
<col width="9%" />
<col width="19%" />
</colgroup>
<thead>
<tr class="header">
<th>patient_id</th>
<th>old_stage</th>
<th>new_stage</th>
<th>survival_months</th>
<th>event</th>
<th>vital_status</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>PT0001</td>
<td>Stage_I</td>
<td>Stage_IA</td>
<td>48.2</td>
<td>0</td>
<td>Alive</td>
</tr>
<tr class="even">
<td>PT0002</td>
<td>Stage_II</td>
<td>Stage_IIB</td>
<td>23.7</td>
<td>1</td>
<td>Deceased</td>
</tr>
<tr class="odd">
<td>PT0003</td>
<td>Stage_III</td>
<td>Stage_IIIA</td>
<td>15.3</td>
<td>1</td>
<td>Deceased</td>
</tr>
</tbody>
</table>
</div>
<div id="loading-your-data" class="section level2">
<h2>Loading Your Data</h2>
<ol style="list-style-type: decimal">
<li><strong>Import your dataset</strong> into jamovi (CSV, Excel, SPSS,
etc.)</li>
<li><strong>Ensure staging variables are factors</strong> with
appropriate level ordering</li>
<li><strong>Check survival time is numeric</strong> and in consistent
units</li>
<li><strong>Verify event variable</strong> is either 0/1 (numeric) or
Alive/Dead (factor)</li>
</ol>
</div>
</div>
<div id="using-the-stage-migration-analysis-module" class="section level1">
<h1>Using the Stage Migration Analysis Module</h1>
<div id="step-1-access-the-module" class="section level2">
<h2>Step 1: Access the Module</h2>
<ol style="list-style-type: decimal">
<li>Navigate to <strong>Analyses</strong> → <strong>SurvivalD</strong> →
<strong>ClinicoPath Survival</strong></li>
<li>Select <strong>Stage Migration Analysis</strong></li>
</ol>
</div>
<div id="step-2-variable-selection" class="section level2">
<h2>Step 2: Variable Selection</h2>
<div id="required-variables" class="section level3">
<h3>Required Variables</h3>
<ol style="list-style-type: decimal">
<li><strong>Original Stage</strong>: Select the variable representing
the original staging system
<ul>
<li>Must be a factor variable</li>
<li>Example: <code>tnm_7th_edition</code>, <code>old_stage</code></li>
</ul></li>
<li><strong>New Stage</strong>: Select the variable representing the new
staging system
<ul>
<li>Must be a factor variable<br />
</li>
<li>Example: <code>tnm_8th_edition</code>, <code>new_stage</code></li>
</ul></li>
<li><strong>Survival Time</strong>: Select the time-to-event variable
<ul>
<li>Must be numeric</li>
<li>Should be in consistent units (months, years)</li>
<li>Example: <code>survival_months</code>,
<code>follow_up_time</code></li>
</ul></li>
<li><strong>Event</strong>: Select the event indicator variable
<ul>
<li>Can be numeric (0/1) or factor (Alive/Dead)</li>
<li>Example: <code>event</code>, <code>vital_status</code></li>
</ul></li>
<li><strong>Event Level</strong>: If using a factor event variable,
specify which level indicates the event
<ul>
<li>Example: “Deceased”, “Dead”, “Event”</li>
</ul></li>
</ol>
</div>
</div>
<div id="step-3-configure-analysis-options" class="section level2">
<h2>Step 3: Configure Analysis Options</h2>
<div id="plot-options" class="section level3">
<h3>Plot Options</h3>
<ol style="list-style-type: decimal">
<li><strong>Show Migration Plot</strong>: Enables alluvial/Sankey
diagram showing patient flow between stages
<ul>
<li>Recommended: <strong>Enabled</strong> for visual understanding</li>
</ul></li>
<li><strong>Survival Plot Type</strong>: Controls how survival curves
are displayed
<ul>
<li><strong>Separate plots</strong>: Shows full Kaplan-Meier plots for
each staging system</li>
<li><strong>Side by side</strong>: Focuses on direct stage
comparisons</li>
</ul></li>
<li><strong>Show Confidence Intervals</strong>: Adds 95% confidence
intervals to survival curves
<ul>
<li>Recommended for formal presentations</li>
</ul></li>
</ol>
</div>
<div id="analysis-options" class="section level3">
<h3>Analysis Options</h3>
<ol style="list-style-type: decimal">
<li><strong>Analyze Will Rogers Phenomenon</strong>: Performs detailed
analysis of the phenomenon
<ul>
<li>Recommended: <strong>Enabled</strong> for comprehensive
analysis</li>
<li>Compares survival within stages between migrated vs. non-migrated
patients</li>
</ul></li>
</ol>
</div>
</div>
<div id="step-4-interpret-results" class="section level2">
<h2>Step 4: Interpret Results</h2>
<p>The analysis produces several key outputs:</p>
<div id="migration-summary-table" class="section level3">
<h3>Migration Summary Table</h3>
<p><strong>Key Metrics:</strong> - <strong>Total patients</strong>:
Overall sample size - <strong>Unchanged stage</strong>: Number of
patients remaining in the same stage - <strong>Stage migration
(%)</strong>: Percentage of patients who changed stages -
<strong>Upstaging (%)</strong>: Percentage moved to higher stages -
<strong>Downstaging (%)</strong>: Percentage moved to lower stages -
<strong>Chi-square</strong>: Statistical test for association between
staging systems</p>
<p><strong>Interpretation:</strong> - Migration rates &gt;20% indicate
substantial staging changes - Significant chi-square suggests non-random
migration patterns - Balance of upstaging vs. downstaging reveals
revision direction</p>
</div>
<div id="stage-distribution-comparison" class="section level3">
<h3>Stage Distribution Comparison</h3>
<p>Shows how patient distribution changes between staging systems:</p>
<p><strong>Columns:</strong> - <strong>Stage</strong>: Individual stage
categories - <strong>Original Count/%)</strong>: Distribution in
original system - <strong>New Count/(%)</strong>: Distribution in new
system<br />
- <strong>Change</strong>: Percentage point change</p>
<p><strong>Interpretation:</strong> - Large changes indicate major
revision impact - Shifts toward early/late stages reveal staging drift -
Balanced changes suggest refinement rather than systematic bias</p>
</div>
<div id="stage-migration-matrix" class="section level3">
<h3>Stage Migration Matrix</h3>
<p>Cross-tabulation showing exact patient flow between stages:</p>
<p><strong>Features:</strong> - Rows: Original staging system - Columns:
New staging system - Values: Patient counts and percentages</p>
<p><strong>Interpretation:</strong> - Diagonal elements: Patients
remaining in equivalent stages - Off-diagonal elements: Migration
patterns - High off-diagonal values indicate significant
reclassification</p>
</div>
<div id="prognostic-performance-comparison" class="section level3">
<h3>Prognostic Performance Comparison</h3>
<p>Compares discriminative ability between staging systems:</p>
<p><strong>Metrics:</strong> - <strong>C-index (Harrell’s)</strong>:
Measures discriminative ability (0.5 = random, 1.0 = perfect) -
<strong>Log-rank test</strong>: Tests for survival differences within
each system - <strong>AIC</strong>: Model quality measure (lower is
better)</p>
<p><strong>Interpretation:</strong> - C-index improvement &gt;0.02 is
clinically meaningful - Lower AIC in new system suggests better model
fit - Stronger log-rank statistics indicate better stage separation</p>
</div>
<div id="will-rogers-phenomenon-analysis" class="section level3">
<h3>Will Rogers Phenomenon Analysis</h3>
<p>Identifies evidence of the phenomenon by comparing survival within
stages:</p>
<p><strong>Columns:</strong> - <strong>Stage</strong>: Original stage
being analyzed - <strong>Unchanged N</strong>: Patients remaining in
same stage - <strong>Unchanged Median</strong>: Median survival for
unchanged patients - <strong>Migrated N</strong>: Patients moving to
different stages - <strong>Migrated Median</strong>: Median survival for
migrated patients - <strong>p-value</strong>: Test comparing unchanged
vs. migrated survival</p>
<p><strong>Interpretation:</strong> - Significant p-values indicate Will
Rogers phenomenon - Different median survivals between groups confirm
the effect - Multiple significant stages suggest systematic migration
bias</p>
</div>
</div>
<div id="step-5-visual-interpretation" class="section level2">
<h2>Step 5: Visual Interpretation</h2>
<div id="migration-flow-plot" class="section level3">
<h3>Migration Flow Plot</h3>
<p>The alluvial/Sankey diagram visualizes patient flow:</p>
<p><strong>Elements:</strong> - <strong>Left axis</strong>: Original
staging system - <strong>Right axis</strong>: New staging system -
<strong>Flow bands</strong>: Patient migration pathways - <strong>Band
thickness</strong>: Proportional to patient numbers</p>
<p><strong>Interpretation:</strong> - Thick diagonal flows indicate
stage stability - Curved flows show migration patterns - Complex flow
patterns suggest major revision impact</p>
</div>
<div id="survival-comparison-plots" class="section level3">
<h3>Survival Comparison Plots</h3>
<p>Kaplan-Meier curves for each staging system:</p>
<p><strong>Features:</strong> - <strong>Separate plots</strong>: Full
survival curves for each system - <strong>Side-by-side</strong>: Direct
comparison of equivalent stages - <strong>Confidence intervals</strong>:
Statistical uncertainty bounds</p>
<p><strong>Interpretation:</strong> - Better curve separation indicates
improved discrimination - Crossing curves suggest staging
inconsistencies - Similar overall survival confirms unchanged patient
outcomes</p>
</div>
<div id="concordance-index-plot" class="section level3">
<h3>Concordance Index Plot</h3>
<p>Bar chart comparing discriminative performance:</p>
<p><strong>Elements:</strong> - <strong>Original System</strong>:
C-index for original staging - <strong>New System</strong>: C-index for
new staging<br />
- <strong>Improvement</strong>: Absolute and percentage change</p>
<p><strong>Interpretation:</strong> - Higher bars indicate better
discrimination - Positive improvement suggests staging enhancement -
Magnitude reflects clinical significance</p>
</div>
</div>
</div>
<div id="clinical-applications" class="section level1">
<h1>Clinical Applications</h1>
<div id="use-case-1-tnm-staging-revision-impact" class="section level2">
<h2>Use Case 1: TNM Staging Revision Impact</h2>
<p><strong>Scenario</strong>: Evaluate impact of TNM 8th edition on lung
cancer staging</p>
<p><strong>Analysis Steps:</strong> 1. Load dataset with both TNM 7th
and 8th edition stages 2. Set “tnm_7th” as original stage, “tnm_8th” as
new stage 3. Use overall survival as endpoint 4. Enable Will Rogers
analysis</p>
<p><strong>Expected Findings:</strong> - Migration rate 25-40% for lung
cancer - Improved C-index for 8th edition (typically +0.02 to +0.05) -
Evidence of Will Rogers phenomenon in Stage II/III patients - Better
survival separation in new system</p>
</div>
<div id="use-case-2-institutional-staging-consistency" class="section level2">
<h2>Use Case 2: Institutional Staging Consistency</h2>
<p><strong>Scenario</strong>: Compare staging between different time
periods</p>
<p><strong>Analysis Steps:</strong> 1. Create “era” variable (e.g.,
2010-2015 vs. 2016-2020) 2. Compare staging distributions across eras 3.
Assess for staging drift or improvement</p>
<p><strong>Expected Findings:</strong> - Temporal changes in stage
distribution - Improved prognostic performance over time - Evidence of
stage migration due to better imaging</p>
</div>
<div id="use-case-3-pathology-subspecialty-analysis" class="section level2">
<h2>Use Case 3: Pathology Subspecialty Analysis</h2>
<p><strong>Scenario</strong>: Evaluate impact of subspecialist review on
staging</p>
<p><strong>Analysis Steps:</strong> 1. Compare initial staging
vs. subspecialist review 2. Focus on difficult cases or borderline
stages 3. Assess survival impact of reclassification</p>
<p><strong>Expected Findings:</strong> - Systematic upstaging or
downstaging patterns - Improved prognostic accuracy - Clinical impact of
subspecialist expertise</p>
</div>
</div>
<div id="advanced-analysis-tips" class="section level1">
<h1>Advanced Analysis Tips</h1>
<div id="sample-size-considerations" class="section level2">
<h2>Sample Size Considerations</h2>
<ul>
<li><strong>Minimum</strong>: 100 patients with adequate follow-up</li>
<li><strong>Recommended</strong>: 200+ patients for robust Will Rogers
analysis</li>
<li><strong>Power</strong>: Consider event rate and median follow-up
time</li>
</ul>
</div>
<div id="statistical-considerations" class="section level2">
<h2>Statistical Considerations</h2>
<ol style="list-style-type: decimal">
<li><strong>Censoring</strong>: Ensure adequate follow-up in both
staging systems</li>
<li><strong>Competing Risks</strong>: Consider disease-specific
vs. overall survival</li>
<li><strong>Time Bias</strong>: Account for temporal changes in
treatment</li>
<li><strong>Institution Bias</strong>: Consider multi-institutional
validation</li>
</ol>
</div>
<div id="interpretation-guidelines" class="section level2">
<h2>Interpretation Guidelines</h2>
<div id="evidence-of-will-rogers-phenomenon" class="section level3">
<h3>Evidence of Will Rogers Phenomenon</h3>
<p><strong>Strong Evidence:</strong> - Migration rate &gt;30% - Multiple
stages with significant Will Rogers tests - Improved stage-specific
survival without overall improvement - C-index improvement primarily
from redistribution</p>
<p><strong>Weak Evidence:</strong> - Migration rate &lt;15% - Few
significant Will Rogers tests - Genuine improvement in C-index - Overall
survival improvement</p>
</div>
<div id="clinical-significance" class="section level3">
<h3>Clinical Significance</h3>
<p><strong>Clinically Meaningful Changes:</strong> - C-index improvement
&gt;0.02 - Stage migration affecting &gt;20% of patients - Survival
differences &gt;6 months between systems - Impact on treatment decision
thresholds</p>
</div>
</div>
<div id="quality-assurance" class="section level2">
<h2>Quality Assurance</h2>
<div id="data-validation" class="section level3">
<h3>Data Validation</h3>
<ol style="list-style-type: decimal">
<li><strong>Staging Accuracy</strong>: Verify both staging systems use
same criteria</li>
<li><strong>Missing Data</strong>: Assess pattern and impact of missing
stages</li>
<li><strong>Follow-up Adequacy</strong>: Ensure sufficient events and
follow-up</li>
<li><strong>Covariate Balance</strong>: Check for confounding
variables</li>
</ol>
</div>
<div id="results-validation" class="section level3">
<h3>Results Validation</h3>
<ol style="list-style-type: decimal">
<li><strong>External Validation</strong>: Test findings in independent
cohort</li>
<li><strong>Sensitivity Analysis</strong>: Test robustness to
assumptions</li>
<li><strong>Clinical Review</strong>: Confirm findings make clinical
sense</li>
<li><strong>Literature Comparison</strong>: Compare to published staging
studies</li>
</ol>
</div>
</div>
</div>
<div id="reporting-results" class="section level1">
<h1>Reporting Results</h1>
<div id="key-elements-to-include" class="section level2">
<h2>Key Elements to Include</h2>
<div id="methods-section" class="section level3">
<h3>Methods Section</h3>
<pre><code>Stage migration analysis was performed using the ClinicoPath module in jamovi. 
Patients were classified according to both [original system] and [new system] 
staging criteria. Migration patterns were quantified using cross-tabulation 
and chi-square tests. Prognostic performance was compared using Harrell&#39;s 
C-index and log-rank tests. The Will Rogers phenomenon was assessed by 
comparing survival between patients who remained in the same stage versus 
those who migrated to different stages.</code></pre>
</div>
<div id="results-section" class="section level3">
<h3>Results Section</h3>
<pre><code>Of [N] patients analyzed, [X]% experienced stage migration between the 
[original] and [new] staging systems (p&lt;0.001). The C-index improved from 
[old C-index] to [new C-index] (improvement: +[change], [%] increase). 
Evidence of the Will Rogers phenomenon was observed in [N] stages, with 
significant survival differences between migrated and non-migrated patients 
(p&lt;0.05). Migration predominantly involved [describe pattern].</code></pre>
</div>
<div id="visual-presentation" class="section level3">
<h3>Visual Presentation</h3>
<ol style="list-style-type: decimal">
<li><strong>Migration flow diagram</strong> showing patient
pathways</li>
<li><strong>Side-by-side survival curves</strong> for key stages</li>
<li><strong>C-index comparison</strong> bar chart</li>
<li><strong>Will Rogers analysis table</strong> for significant
stages</li>
</ol>
</div>
</div>
<div id="common-pitfalls" class="section level2">
<h2>Common Pitfalls</h2>
<div id="analytical-pitfalls" class="section level3">
<h3>Analytical Pitfalls</h3>
<ol style="list-style-type: decimal">
<li><strong>Insufficient Follow-up</strong>: Premature analysis with
inadequate follow-up</li>
<li><strong>Selection Bias</strong>: Non-representative patient
population</li>
<li><strong>Temporal Confounding</strong>: Changes in treatment
concurrent with staging</li>
<li><strong>Multiple Testing</strong>: Not adjusting for multiple
comparisons</li>
</ol>
</div>
<div id="interpretation-pitfalls" class="section level3">
<h3>Interpretation Pitfalls</h3>
<ol style="list-style-type: decimal">
<li><strong>Causation vs. Association</strong>: Assuming staging changes
cause outcome improvements</li>
<li><strong>Clinical vs. Statistical</strong>: Overinterpreting small
but significant changes</li>
<li><strong>Generalizability</strong>: Extrapolating single-institution
findings</li>
<li><strong>Complexity</strong>: Over-interpreting complex migration
patterns</li>
</ol>
</div>
</div>
</div>
<div id="conclusion" class="section level1">
<h1>Conclusion</h1>
<p>The Stage Migration Analysis module provides comprehensive tools for
understanding the impact of staging system changes on clinical outcomes.
By systematically analyzing migration patterns, prognostic performance,
and the Will Rogers phenomenon, researchers and clinicians can:</p>
<ol style="list-style-type: decimal">
<li><strong>Objectively evaluate</strong> staging system revisions</li>
<li><strong>Detect statistical artifacts</strong> that may mislead
clinical interpretation</li>
<li><strong>Quantify improvements</strong> in prognostic
discrimination</li>
<li><strong>Guide clinical practice</strong> based on evidence-based
staging analysis</li>
</ol>
<p>Understanding stage migration is crucial for proper interpretation of
cancer outcomes research and for making informed decisions about staging
system adoption in clinical practice.</p>
<div id="further-resources" class="section level2">
<h2>Further Resources</h2>
<ul>
<li><strong>ClinicoPath Documentation</strong>: Comprehensive module
reference</li>
<li><strong>TNM Classification Guidelines</strong>: Official staging
criteria</li>
<li><strong>Survival Analysis Methods</strong>: Statistical background
and methods</li>
<li><strong>Will Rogers Literature</strong>: Published examples and
methodological papers</li>
</ul>
<p>For questions or support, please refer to the ClinicoPath
documentation or contact the development team.</p>
</div>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
